Vita Coco (COCO) Executive Chairman reports 30,000-share sale under 10b5-1 plan
Rhea-AI Filing Summary
Michael Kirban, Executive Chairman of Vita Coco Company, Inc. (COCO), reported an open-market sale of 30,000 shares of common stock executed under a Rule 10b5-1 trading plan at a weighted average price of $41.719 per share. The Form 4 shows the reporting person retains significant holdings: 1,549,049 shares indirectly held by the Michael Kirban 2010 Trust, 615,681 shares indirectly held by the Michael Kirban Revocable Trust, and 127,629 shares directly held. Multiple stock options across various strike prices and vesting schedules are also disclosed, including fully exercisable options and several tranches that vest over coming years.
Positive
- None.
Negative
- Reported sale of 30,000 common shares executed on 09/17/2025 at a weighted average price of $41.719 per share
- Reduction in direct holdings by the 30,000-share sale (reported as a disposal)
Insights
TL;DR: Insider sale of 30,000 shares under a 10b5-1 plan; substantial trust holdings and vested options remain.
The filing documents a planned disposition executed under a Rule 10b5-1 plan, which provides procedural protection against accusations of trading on material nonpublic information. The reported weighted average sale price was $41.719 per share. While the sale reduces direct holdings by 30,000 shares, the reporting person continues to hold large indirect and direct positions through trusts totaling over 2.1 million shares combined as reported. Several non-qualified stock options with varied strike prices and vesting schedules are outstanding, including options fully vested and exercisable, which could affect future dilution if exercised.
TL;DR: Transaction follows a documented 10b5-1 plan; disclosure aligns with Section 16 reporting requirements.
The Form 4 is properly filed and includes standard explanatory footnotes identifying the trading plan and trust ownership. The signature by an attorney-in-fact is provided. The disclosure of option vesting schedules and exercisability is appropriate for transparency around potential future insider-driven equity changes. No amendments or unusual reporting flags are present in the filing text provided.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 30,000 | $41.719 | $1.25M |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.50 to $42.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Michael Kirban 2010 Trust. These shares are held by the Michael Kirban Revocable Trust. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
